FIM
TEVA icon

Fernwood Investment Management’s Teva Pharmaceuticals TEVA Stock Holding History

Fernwood Investment Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-18,150
Closed -$319K – 154
2017
Q3 		$319K Sell
18,150
-200
-1% -$4.5K 0.2% 106
2017
Q2 		$610K Buy
18,350
+2,500
+16% +$77.4K 0.44% 64
2017
Q1 		$509K Buy
15,850
+200
+1% +$6.83K 0.41% 66
2016
Q4 		$567K Sell
15,650
-2,241
-13% -$89.5K 0.54% 51
2016
Q3 		$823K Hold
17,891
– – 0.75% 45
2016
Q2 		$899K Sell
17,891
-13
-0.1% -$692 0.88% 35
2016
Q1 		$958K Sell
17,904
-6,714
-27% -$394K 0.97% 33
2015
Q4 		$1.62M Buy
24,618
+5,068
+26% +$313K 1.38% 19
2015
Q3 		$1.1M Buy
19,550
+1,100
+6% +$71.3K 0.97% 35
2015
Q2 		$1.09M Buy
18,450
+1,000
+6% +$61.7K 0.86% 41
2015
Q1 		$1.09M Buy
17,450
+1,400
+9% +$81.4K 0.89% 39
2014
Q4 		$923K Buy
16,050
+7,800
+95% +$435K 0.79% 38
2014
Q3 		$443K Sell
8,250
-300
-4% -$15.9K 0.38% 66
2014
Q2 		$448K Sell
8,550
-750
-8% -$38.3K 0.37% 70
2014
Q1 		$491K Sell
9,300
-2,151
-19% -$99.4K 0.46% 62
2013
Q4 		$459K Buy
+11,451
New +$451K 0.3% 84

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
BC
Brahman Capital New York $275M AUM 18.08% 1-Year Est. Return

Fernwood Investment Management's TEVA Position: Q4 2017 in Review

Fernwood Investment Management sold out of Teva Pharmaceuticals (TEVA) in Q4 2017, closing a stake of 18,150 shares — an estimated $319K sold.

Fernwood Investment Management first reported a position in TEVA in Q4 2013 and held it in 16 quarters. The position peaked at $1.62M in Q4 2015. 508 funds tracked by Wall St. Rank hold TEVA as of Q4 2017.

  • Fernwood Investment Management reported no remaining Teva Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • Fernwood Investment Management sold 18,150 Teva Pharmaceuticals shares in Q4 2017, an estimated $319K.
  • Fernwood Investment Management first reported a position in Teva Pharmaceuticals in Q4 2013 and held it in 16 quarters.
  • Fernwood Investment Management's Teva Pharmaceuticals position peaked at $1.62M in Q4 2015.
  • 508 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2017.

Based on Fernwood Investment Management's 13F filing for Q4 2017, filed 5 Feb 2018.